
News
-
$25.5m of new investment from a fund managed by Athyrium Capital Management
Read More -
Achieving More Meaningful Patient Engagement in Rare Disease Trials
Read More -
AbbVie and uMotif support Rheumatoid Arthritis patients with Bring Your Own Device approach to capturing study data
Read More -
uMotif collaborates with The University of Manchester on body mapping tool
Read More -
uMotif evolves leadership team with appointment of Steve Rosenberg as CEO
Read More -
uMotif Adds eClinical Industry Veteran Steve Rosenberg to Board of Directors
Read More -
uMotif and VirTrial partner to further expand decentralized clinical trial capabilities
Read More -
AWS Case Study: The benefits and efficiencies of building the uMotif platform on Amazon Web Services infrastructure
Read More -
On-Demand Webinar: Powering Virtual Trials – In the Cloud
Read More